SMOKING INFLUENCES THE ATHEROGENIC POTENTIAL OF LOW-DENSITY-LIPOPROTEIN

被引:0
|
作者
SCHEFFLER, E
WIEST, E
WOEHRLE, J
OTTO, I
SCHULZ, I
HUBER, L
ZIEGLER, R
DRESEL, HA
机构
[1] UNIV HEIDELBERG, MED KLIN, W-6900 HEIDELBERG, GERMANY
[2] BOEHRINGER MANNHEIM GMBH, ARTERIOSKLEROSEFORSCH ABT, W-6800 MANNHEIM, GERMANY
来源
CLINICAL INVESTIGATOR | 1992年 / 70卷 / 3-4期
关键词
LOW-DENSITY LIPOPROTEIN; VITAMIN-E; SMOKING; LIPID PEROXIDATION; ATHEROSCLEROSIS;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The possible influence of smoking on the low-density lipoprotein (LDL) and its biological activity was investigated. Plasma LDL was prepared from healthy male smokers and nonsmokers, and oxidized with Cu (11) as prooxidant. Oxidized LDL from smokers generated significantly more lipid-peroxidation products, so-called thiobarbituric acid reactive substances (TBARS), when compared to oxidized nonsmoker LDL. Analysis of vitamin E levels in LDL obtained from both smokers and nonsmokers revealed that the vitamin E content of smoker LDL was significantly less than that of nonsmoker LDL. The amounts of cholesteryl esters formed in cultured P388. D.1 macrophages were greater in the presence of smoker LDL than with nonsmoker LDL. The data suggest that some of the proatherogenic effects of smoking may be related to oxidative modification of LDL and alteration of its biological activity.
引用
下载
收藏
页码:263 / 268
页数:6
相关论文
共 50 条
  • [21] LIPOPROTEIN(A) IS INCLUDED IN LOW-DENSITY-LIPOPROTEIN BY NCEP DEFINITION
    WARNICK, GR
    CLINICAL CHEMISTRY, 1994, 40 (11) : 2115 - 2116
  • [22] PLATELET LOW-DENSITY-LIPOPROTEIN RECEPTORS
    HASSALL, DG
    BRUCKDORFER, KR
    BIOCHEMICAL SOCIETY TRANSACTIONS, 1985, 13 (06) : 1189 - 1190
  • [23] LOW-DENSITY-LIPOPROTEIN APHERESIS - REPLY
    THOMPSON, GR
    LANCET, 1995, 346 (8967): : 117 - 117
  • [24] CALCULATION OF LOW-DENSITY-LIPOPROTEIN CHOLESTEROL
    MASSE, J
    ARCHIVES OF INTERNAL MEDICINE, 1991, 151 (04) : 810 - 810
  • [25] CELLULAR ACTIVATION BY LOW-DENSITY-LIPOPROTEIN
    KNORR, M
    VETTER, W
    PLETSCHER, A
    BLOCK, LH
    CLINICAL RESEARCH, 1987, 35 (01): : A3 - A3
  • [26] INDICATIONS FOR LOW-DENSITY-LIPOPROTEIN APHERESIS
    GORDON, BR
    STEIN, E
    JONES, P
    ILLINGWORTH, DR
    AMERICAN JOURNAL OF CARDIOLOGY, 1994, 74 (11): : 1109 - 1112
  • [27] INVIVO IMAGING OF LOW-DENSITY-LIPOPROTEIN
    TWEDDEL, A
    MARTIN, W
    DAGEN, M
    LIEBERMAN, P
    SHEPHERD, J
    HUTTON, I
    BRITISH HEART JOURNAL, 1990, 64 (01): : 99 - 99
  • [28] INFLUENCE OF EARLY DIABETIC NEPHROPATHY ON VERY LOW-DENSITY-LIPOPROTEIN (VLDL), INTERMEDIATE DENSITY LIPOPROTEIN (IDL), AND LOW-DENSITY-LIPOPROTEIN (LDL) COMPOSITION
    WINOCOUR, PH
    DURRINGTON, PN
    BHATNAGAR, D
    ISHOLA, M
    MACKNESS, M
    ARROL, S
    ATHEROSCLEROSIS, 1991, 89 (01) : 49 - 57
  • [29] LOW-DENSITY-LIPOPROTEIN KINETICS IN A FAMILY HAVING DEFECTIVE LOW-DENSITY-LIPOPROTEIN RECEPTORS IN WHICH HYPERCHOLESTEROLEMIA IS SUPPRESSED
    VEGA, GL
    HOBBS, HH
    GRUNDY, SM
    ARTERIOSCLEROSIS AND THROMBOSIS, 1991, 11 (03): : 578 - 585
  • [30] RADIOHALOGENATED LOW-DENSITY-LIPOPROTEIN - POTENTIAL AGENTS FOR THE VISUALIZATION OF ATHEROSCLEROTIC LESIONS
    MOERLEIN, SM
    DALAL, KB
    YANO, Y
    EBBE, S
    LINDGREN, FT
    BUDINGER, TF
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 1986, 23 (10-12): : 1307 - 1308